Contract: $754,737 - National Institutes of Health - Aug. 31, 2009
0% voted satisfied - 100% voted not satisfied - 1 vote(s) cast
Award Description: (ARRA) Early therapeutics development with a phase II emphasis. The objectives of these contracts are to conduct Phase 2 and early clinical trials of NCI-sponsored agents to evaluate biologic effects of these agents on their molecular targets, to evaluate other relevant biologic effects and to determine clinically relevant outcomes/correlates. Major emphasis is on Phase 2 studies, pilot protocols that explore promising combination therapies, and high priority studies that are pivotal for drug development and require rapid initiation, completion, and data reporting.
Project Description: The project, as defined in the Award Description field, is being initiated.
Jobs Summary: Not applicable (Total jobs reported: 0)
Project Status: Not Started
This award's data was last updated on Aug. 31, 2009. Help expand these official descriptions using the wiki below.